Author

Delphine S Courvoisier

Department of Medicine, Medical Faculty, Geneva University, Geneva, Switzerland. Division of Rheumatology, University Hospitals of Geneva, CH-1206 Geneva, Switzerland.;

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Axel FinckhiD· 2 shared Matthias JarlborgiD· 2 shared Alexandra Circiumaru· 1 shared Arnaud Huard· 1 shared Assunta Caruso· 1 shared Burkhard Moeller· 1 shared Celine Lamacchia· 1 shared Cem GabayiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Axel FinckhORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 4, 2026

IL-23 licenses the transition from preclinical autoimmunity to inflammatory arthritis through IL-17A-dependent mechanisms

Matthias Jarlborg, Alexandra Circiumaru, Celine Lamacchia…·Cem Gabay

This study shows IL-23 promotes the transition from preclinical autoimmunity to arthritis by enhancing IL-17A and IFN-gamma production, and identifies IL-23 pathway changes in at-risk individuals.

DOI 10.64898/2026.10.30.762860

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 3, 2026

Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality

Seimia Chebbi, Denis Mongin, Delphine S Courvoisier…·Matthias Jarlborg

This study evaluates serum calprotectin as a biomarker for disease activity, severity, cardiovascular risk, and mortality in inflammatory rheumatic diseases, finding it to be a better predictor than CRP in certain contexts.

DOI 10.64898/2026.10.30.763141

humanproteomics

𝕏 PostBluesky